Search results for: 'diseas tech eu'

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

The acute impact of climate change due to growing GHG emissions highlights the need for the technologies that can reduce said emissions while preparing the world s population for a scenario in which international targets are not achieved. While mitigation technologies seek to reduce or offset GHG emissions, adaptation technologies prepare communiti...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

06 Oct 2021  |  North America  |  Market Research

US Chronic Disease Management Growth Opportunities

Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management

Infographics

×

Key Issues Addressed

The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

The climate emergency and the global economy's pivotal shift to net zero have prompted a need for transparent and accountable environmental, social, and governance (ESG) frameworks that can shape the transition of sustainability and the circular economy. The future of ESG, sustainability, and the circular economy will rely on delivering more with l...

Research Scope: Political, Economic, Social, Technology, Legal, and Environment Analysis Geographic Scope: US, UK, EU What makes this study unique? It analyses the changing political, economic, social, technological, legal, and environment across the US, UK, EU, while highlighting the implications of these changes. Key Questions Answered: What i...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...